Literature DB >> 8965913

Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis.

J F Seymour, A R Dunn, J M Vincent, J J Presneill, M C Pain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8965913     DOI： 10.1056/NEJM199612193352513

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  The molecular basis of pulmonary alveolar proteinosis.

Authors:  Brenna Carey; Bruce C Trapnell
Journal:  Clin Immunol       Date:  2010-03-25       Impact factor: 3.969

3.  Gasping for a Diagnosis.

Authors:  Kristin D'Silva; Sarah Brown; Gary M Hunninghake; Marina Vivero; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2019-03-07       Impact factor: 91.245

4.  Pulmonary alveolar proteinosis and successful therapy with combined lavage procedures: Case reports.

Authors:  Nalan Demır Firat; Aydin Cıledağ; Pinar Akin Kabalak; Demet Karnak; Başak Ceyda Meco; Zekerıyya Alanoğlu; Neslıhan Alkiş
Journal:  Exp Ther Med       Date:  2011-03-18       Impact factor: 2.447

5.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

6.  Whole lung lavage for pulmonary alveolar proteinosis.

Authors:  S Jayaraman; A R Gayathri; P Senthil Kumar; Rajeev Santosham; Rajan Santosham; R Narasimhan
Journal:  Lung India       Date:  2010-01

7.  Clinical features and outcomes of idiopathic pulmonary alveolar proteinosis in Korean population.

Authors:  Min Kwang Byun; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Jae Jeong Shim; Seung Ick Cha; Soo-Taek Uh; Choon Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Moo Suk Park
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

8.  Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Authors:  Spyros A Papiris; Panagiotis Tsirigotis; Likurgos Kolilekas; Georgia Papadaki; Andriana I Papaioannou; Christina Triantafillidou; Anastasia Papaporfyriou; Anna Karakatsani; Konstantinos Kagouridis; Matthias Griese; Effrosyni D Manali
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

9.  Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.

Authors:  Bruce C Trapnell; Yoshikazu Inoue; Francesco Bonella; Cliff Morgan; Stéphane Jouneau; Elisabeth Bendstrup; Ilaria Campo; Spyros A Papiris; Etsuro Yamaguchi; Erdogan Cetinkaya; Mikhail M Ilkovich; Mordechai R Kramer; Marcel Veltkamp; Michael Kreuter; Tomohisa Baba; Cecilia Ganslandt; Inge Tarnow; Grant Waterer; Taneli Jouhikainen
Journal:  N Engl J Med       Date:  2020-09-07       Impact factor: 91.245

Review 10.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.